neurocrine market cap 2022

On December 30, 2022, Neurocrine Biosciences (NBIX) had a market capitalization of $12B, based on 100.8M shares at a price of $119.44.

DATE CLOSE VOLUME OUTSTANDING MARKET CAP
December 30 2022
$119.44
508,562
100,800,000
$12,039,552,000.00
December 29 2022
$120.20
297,517
100,800,000
$12,116,160,000.00
December 28 2022
$118.68
297,452
100,800,000
$11,962,944,000.00
December 27 2022
$118.93
394,065
100,800,000
$11,988,144,000.00
December 23 2022
$120.31
329,483
100,800,000
$12,127,248,000.00
December 22 2022
$122.40
375,609
100,800,000
$12,337,920,000.00
December 21 2022
$120.34
680,527
100,800,000
$12,130,272,000.00
December 20 2022
$119.16
741,099
100,800,000
$12,011,328,000.00
December 19 2022
$117.93
797,700
100,800,000
$11,887,344,000.00
December 16 2022
$117.19
1,358,129
100,800,000
$11,812,752,000.00
December 15 2022
$116.69
981,846
100,800,000
$11,762,352,000.00
December 14 2022
$119.24
636,395
100,800,000
$12,019,392,000.00
December 13 2022
$119.00
1,094,265
100,800,000
$11,995,200,000.00
December 12 2022
$119.48
636,171
100,800,000
$12,043,584,000.00
December 09 2022
$117.24
875,792
100,800,000
$11,817,792,000.00
December 08 2022
$120.39
631,659
100,800,000
$12,135,312,000.00
December 07 2022
$121.51
390,944
100,800,000
$12,248,208,000.00
December 06 2022
$120.21
749,223
100,800,000
$12,117,168,000.00
December 05 2022
$124.00
492,926
100,800,000
$12,499,200,000.00
December 02 2022
$126.81
481,858
100,800,000
$12,782,448,000.00
December 01 2022
$126.31
654,342
100,800,000
$12,732,048,000.00
November 30 2022
$127.06
1,647,301
100,800,000
$12,807,648,000.00
November 29 2022
$121.74
718,281
100,800,000
$12,271,392,000.00
November 28 2022
$121.66
496,611
100,800,000
$12,263,328,000.00
November 25 2022
$122.15
283,681
100,800,000
$12,312,720,000.00